Investment Trusts

RTW Biotech Opportunities Ltd

RTW:LSE

RTW Biotech Opportunities Ltd

  • Price (USD)2.10
  • Today's Change-0.03 / -1.41%
  • Shares traded289.45k
  • 1 Year change54.98%
  • Beta1.2423
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼
Total returns on $1000
1Y
Fund/benchmarkChange
PriceRTW Biotech Opportunities Ltd (Ordinary Share)+57.81%
NAVRTW Biotech Opportunities Ltd (Ordinary Share)+35.36%
Morningstar's BenchmarkRussell 2000 Biotech Growth--

Key statistics

On Friday, RTW Biotech Opportunities Ltd (RTW:LSE) closed at 2.10, -9.48% below its 52-week high of 2.32, set on Jan 14, 2026.
52-week range
Today
1.08Apr 08 20252.32Jan 14 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding326.37m
Market cap695.18m USD
Total assets799.62m USD
Total expense ratio--
High2.16
Low2.08
Previous close2.13
Average volume382.28k
YTD Change-2.78%
Beta1.2423
Diluted NAV (est)2.45
Diluted NAV (last pub)2.45
Premium/Discount-14.29%
Net Gearing0.00%
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.